67 related articles for article (PubMed ID: 2014712)
1. [Therapy of organic brain syndrome with nicergoline given once a day].
Ladurner G; Erhart P; Erhart C; Scheiber V
Wien Klin Wochenschr; 1991; 103(1):8-14. PubMed ID: 2014712
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of multi-infarct dementia with nicergoline: double-blind, clinical, psychometric and EEG imaging studies with 2 dosage schedules].
Saletu B; Hochmayer I; Grünberger J; Böhmer F; Paroubek J; Wicke L; Neuhold A
Wien Med Wochenschr; 1987 Nov; 137(22):513-24. PubMed ID: 3324497
[TBL] [Abstract][Full Text] [Related]
3. A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia.
Herrmann WM; Stephan K; Gaede K; Apeceche M
Dement Geriatr Cogn Disord; 1997; 8(1):9-17. PubMed ID: 8997547
[TBL] [Abstract][Full Text] [Related]
4. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study.
Saletu B; Paulus E; Linzmayer L; Anderer P; Semlitsch HV; Grünberger J; Wicke L; Neuhold A; Podreka I
Psychopharmacology (Berl); 1995 Feb; 117(4):385-95. PubMed ID: 7604138
[TBL] [Abstract][Full Text] [Related]
5. Nicergoline in the treatment of dizziness in elderly patients. A review.
Felisati G; Pignataro O; Di Girolamo A; Bruno E; Alessandrini M; Guidetti G; Monzani D; Beldi AM; Mira E; Benazzo M; Pallestrini E; Caligo G; Casani A; Battaglia A
Arch Gerontol Geriatr Suppl; 2004; (9):163-70. PubMed ID: 15207410
[TBL] [Abstract][Full Text] [Related]
6. Effects of intravenous high dose co-dergocrine mesylate ('Hydergine') in elderly patients with severe multi-infarct dementia: a double-blind, placebo-controlled trial.
Arrigo A; Casale R; Giorgi I; Guarnaschelli C; Zelaschi F
Curr Med Res Opin; 1989; 11(8):491-500. PubMed ID: 2680286
[TBL] [Abstract][Full Text] [Related]
7. [Dihydroergocristine in the treatment of organic brain psychosyndrome. Dose-finding study against placebo].
Milvio C
Arzneimittelforschung; 1992 Nov; 42(11A):1399-402. PubMed ID: 1492861
[TBL] [Abstract][Full Text] [Related]
8. [Vascular-induced disorders of cerebral performance in the elderly. Long-term therapy with pentoxifylline and psychological mental training].
Blume J; Rühlmann KU; de la Haye R; Rettig K; Oltmer G
Fortschr Med; 1990 Nov; 108(33):638-42. PubMed ID: 2127040
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
10. [Paroxetine in the treatment of depression in geriatric patients--a double-blind comparative study with fluoxetine].
Schöne W; Ludwig M
Fortschr Neurol Psychiatr; 1994 Sep; 62 Suppl 1():16-8. PubMed ID: 7959520
[TBL] [Abstract][Full Text] [Related]
11. Ergoloids and ischaemic strokes; efficacy and mechanism of action.
Elwan O; Helmy AA; Tamawy ME; Naseer MA; Banhawy IE; Kader AA; Elwan F
J Int Med Res; 1995; 23(3):154-66. PubMed ID: 7649339
[TBL] [Abstract][Full Text] [Related]
12. Relations between symptomatology and brain function in dementias: double-blind, placebo-controlled, clinical and EEG/ERP mapping studies with nicergoline.
Saletu B; Anderer P; Semlitsch HV
Dement Geriatr Cogn Disord; 1997; 8 Suppl 1():12-21. PubMed ID: 9205834
[No Abstract] [Full Text] [Related]
13. Long-Term Nicergoline Treatment of Mild to Moderate Senile Dementia : Results of a Multicentre, Double-Blind, Placebo-Controlled Study.
Nappi G; Bono G; Merlo P; Borromei A; Caltagirone C; Lomeo C; Martucci N; Fabbrini G; Annoni K; Battaglia A
Clin Drug Investig; 1997 Jun; 13(6):308-16. PubMed ID: 27519492
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of clinical efficacy of a venotonic drug: lessons of a therapeutic trial with hemisynthesis diosmin in "heavy legs syndrome"].
Carpentier PH; Mathieu M
J Mal Vasc; 1998 Apr; 23(2):106-12. PubMed ID: 9608923
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamics.
Alvarez XA; Pichel V; Pérez P; Laredo M; Corzo D; Zas R; Fernández-Novoa L; Sempere JM; Díaz J; Cacabelos R
Methods Find Exp Clin Pharmacol; 2000 Sep; 22(7):585-94. PubMed ID: 11196347
[TBL] [Abstract][Full Text] [Related]
16. Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies.
Brannan SK; Mallinckrodt CH; Detke MJ; Watkin JG; Tollefson GD
J Psychiatr Res; 2005 Mar; 39(2):161-72. PubMed ID: 15589564
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
[TBL] [Abstract][Full Text] [Related]
18. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
[TBL] [Abstract][Full Text] [Related]
19. Nicergoline in mild to moderate dementia. A multicenter, double-blind, placebo-controlled study.
Battaglia A; Bruni G; Ardia A; Sacchetti G
J Am Geriatr Soc; 1989 Apr; 37(4):295-302. PubMed ID: 2646350
[TBL] [Abstract][Full Text] [Related]
20. European Pentoxifylline Multi-Infarct Dementia Study.
Eur Neurol; 1996; 36(5):315-21. PubMed ID: 8864715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
